BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment

NEXT STORY
IDBiologics Announces Nature Publication Highlighting Preclinical Results of Ultra-Potent Monoclonal Antibodies Against SARS-CoV-2
PREV STORY
Next Super Stocks on The Move: CEO’s of Predictmedix (OTC: PMEDF) ImagineAR (OTC: IPNFF) NexTech AR Solutions (OTC: NEXCF) Artificial Intelligence & Augmented Reality Technologies Addressing Multibillion Dollar Opportunities in Telemedicine, Entertainment and Video Conferencing & Virtual Tradeshows
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies

author_avatar
NASDAQ Market News

Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development

MEDFORD, N.Y., July 19, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs

author_avatar
NASDAQ Market News